Executives' Comments Stir More Speculation About ABI-MDS Mass Spec Joint Venture | GenomeWeb
NEW YORK (GenomeWeb news) - With the proposed $6.7 billion merger of Applied Biosystems and Invitrogen chugging toward completion, the chief executive of MDS, ABI’s mass-spec joint-venture partner, this week left open the possibility that his firm is at least considering purchasing that business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.